Axogen, Inc. will increase investor engagement in the first quarter of 2026 through participation in three prominent healthcare and life sciences conferences scheduled throughout March. The company's management team will present at the Raymond James 47th Annual Institutional Investors Conference on March 3, followed by appearances at the Leerink Global Healthcare Conference on March 9 and The Citizens Life Sciences Conference on March 10.
Beyond formal presentations at these events, Axogen will conduct one-on-one investor meetings with institutional investors and analysts seeking direct dialogue with company leadership. This multi-conference strategy reflects a deliberate approach to reaching diverse segments of the investment community, from large institutional investors to specialized healthcare-focused funds.
Investors interested in following the company's presentations can access webcasts and related materials through Axogen's investor relations website, providing broader access to the company's investment narrative for those unable to attend in person.